International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Authors
John A. Spertus (ORCID: https://orcid.org/0000-0002-2839-2611)
National Center for Advancing Translational Sciences
Duke Clinical Research Institute
Daiichi Sankyo Europe
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
John A. Spertus, Fátima Rodríguez, Ahmed Elghamaz, Gregory A. Roth et al.
Citations
2 citations
Journal
Circulation Cardiovascular Quality and Outcomes
Topics
Cardiovascular Health and Risk Factors
Field-Weighted Citation Impact (FWCI)
0.80
article
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
John A. Spertus, Fátima Rodríguez, Ahmed Elghamaz, Gregory A. Roth, Nobuhiro Ikemura, Shun Kohsaka, Harmony R. Reynolds, Shaun G. Goodman, David J. Maron, Roxy Senior, Zhuxuan Fu, Sripal Bangalore, Dan Nguyen, Harvey D. White, Renato D. Lópes, Radosław Pracoń, Kreton Mavromatis, William E. Boden, Philip G. Jones, Judith S. Hochman, Aldo P. Maggioni, José López‐Sendón, Balram Bhargava
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Circulation Cardiovascular Quality and OutcomesVol. 17(10)
Institutions
St. Michael's Hospital (CA), Saint Luke's Health System (US), University of Washington (US), Keio University (JP), Hospital Universitario La Paz (ES), Northwick Park Hospital (GB), Atlanta Medical Center (US), Clinical Research Institute (US), Greenlane Clinical Centre (NZ), VA New England Healthcare System (US), Associazione Nazionale Medici Cardiologi Ospedalieri (IT), Hospital La Paz Institute for Health Research (ES), Institute of Cardiology (PL), Saint Luke's Hospital (US), Atlanta VA Medical Center (US), Narodowy Instytut Leków (PL), New York University (US), All India Institute of Medical Sciences (IN), Stanford University (US)
Funders
American Heart Association, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Philips, AstraZeneca, GlaxoSmithKline, Sanofi, Medtronic, Heart and Stroke Foundation of Canada, Cleveland Clinic, Lantheus Medical Imaging, CSL Behring, Regeneron Pharmaceuticals, Amarin Corporation, Arbor Pharmaceuticals, York University, Daiichi-Sankyo, University of Toronto, Novo Nordisk, Servier, HLS Therapeutics, Esperion Therapeutics, National Institutes of Health, St. Jude Medical, Abbott Vascular, American Regent, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences, Duke Clinical Research Institute, Daiichi Sankyo Europe